TG1042 (Adenovirus-interferon-?) in primary cutaneous B-cell lymphomas: a phase II clinical trial.

TG1042 (Adenovirus-interferon-?) in primary cutaneous B-cell lymphomas: a phase II clinical trial. PLoS One. 2014; 9(2):e83670.

View in: PubMed